<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> is a <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare disease</z:e>, that belongs to the aggressive Non-Hodgkin-<z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Next to histology, that shows a characteristic pattern, and immunophenotyping additional cytogenetic and molecular biology techniques are used to demonstrate in most cases a translocation of the oncogen c-myc on chromosome 8 to any of the immunoglobulin genes on chromosome 14, 2 or 22 </plain></SENT>
<SENT sid="2" pm="."><plain>With short term intensive chemotherapies a cure rate of 85-95% of patients with Burkitt-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> can be obtained today </plain></SENT>
</text></document>